Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

HighLife SAS

www.highlifemed.com

Latest From HighLife SAS

Edwards Undeterred By Latest Speed Bump In Transcatheter Mitral Valve Program

Edwards has temporarily paused the FORTIS clinical program evaluating a new transcatheter mitral valve to resolve valve thrombosis issues that emerged in the first 20 patients.

Medical Device

US Heart Valve Treatments Market Fueled By New Transcatheter Valves

The US heart valve treatments market will reach $1.7 billion by 2019, driven by advances in percutaneous heart valve repair and replacement products and a growing number of competitors entering this space. With US sales of transcatheter aortic valve replacement systems set to almost triple in the next several years, the combined US market for products to treat heart valve disorders is expected to grow at a CAGR of 7.7%.

Medical Device Europe

Cyberonics, Sorin Seek Critical Mass With Merger

The yet-to-be-named combined company is predicting big opportunities, particularly, heart failure, sleep apnea and cardiac surgery.

Medical Device

Device/Diagnostics Quarterly Deal Statistics, Q1 2013

Device companies kicked off 2013 by raising $1.1 billion via 45 transactions; the only device M&A transaction in Q1 to exceed the billion-dollar mark was Cardinal Health Inc.’s $2.07 billion acquisition of AssuraMed. Diagnostics firms began 2013 by raising a total of $286 million in the opening quarter, a 46% improvement over Q4 2012’s tally.

Medical Device Deals
See All

Company Information

  • Industry
  • Medical Devices
    • Implantable Devices
    • Surgical Equipment & Devices
      • Minimally or Less Invasive
  • Therapeutic Areas
  • Cardiovascular
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • France
  • Parent & Subsidiaries
  • HighLife SAS
  • Senior Management
  • Georg Börtlein, Pres. & CEO
  • Contact Info
  • HighLife SAS
    Phone: (0)1 72 32 21 15
    33 avenue du Maine
    Paris, 75755
    France
Advertisement
Advertisement
UsernamePublicRestriction

Register